Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No. )

Filed by the Registrant

Filed by a Party other than the Registrant


Check the appropriate box:
☐			Preliminary Proxy Statement
☐			Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐			Definitive Proxy Statement
x			Definitive Additional Materials
☐			Soliciting Material Pursuant to §240.14a-12

DexCom, Inc.

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)


Payment of Filing Fee (Check the appropriate box):
x	No fee required.
☐	Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
	(1)	Title of each class of securities to which transaction applies:
	(2)	Aggregate number of securities to which transaction applies:
	(3)	Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
	(4)	Proposed maximum aggregate value of transaction:
	(5)	Total fee paid:
☐	Fee paid previously with preliminary materials.
☐	Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
	(1)	Amount Previously Paid:
	(2)	Form, Schedule or Registration Statement No.:
	(3)	Filing Party:
	(4)	Date Filed:

Important Notice Regarding the Availability of Proxy Materials for DexCom, Inc.

Stockholders Meeting to be held on

P.O. BOX 8016, CARY, NC 27512-9903

May 19, 2022

For Stockholders as of March 31, 2022

This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting.

To view the proxy materials go to:

www.proxydocs.com/DXCM

To vote your proxy while visiting this site, you will need the 12 digit control number in the box below.

Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on the internet.

CONTROL NUMBER

For a convenient way to view proxy materials

and VOTE go to www.proxydocs.com/DXCM

Have the 12 digit control number located in the shaded box above available when you access the website and follow the instructions

If you want to receive a paper or e-mail copy of the proxy material, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year's shareholder meeting, you must make this request on or before May 9, 2022

To order paper materials, use one of the following methods.

INTERNET

TELEPHONE

*E-MAIL

www.investorelections.com/DXCM

(866) 648-8133

paper@investorelections.com

When requesting via the Internet or telephone you will need the 12 digit control number located in the shaded gray box above.

* If requesting material by e-mail, please send a blank e-mail with the 12 digit control number (located above) in the subject line. No other requests, instructions or other inquiries should be included with your e-mail requesting material.

DexCom, Inc.

Meeting Information

Meeting Materials:

Notice of Meeting and Proxy Statement & Annual Report or Form 10-K

Meeting Type:

Annual Meeting of Stockholders

Date:

Thursday, May 19, 2022

Time:

02:00 PM, Pacific Time

Place:

Annual Meeting to be held live via the Internet

Please visit www.proxydocs.com/DXCM for more details

You must pre-register to attend the meeting online and/or participate at the email address indicated.

SEE REVERSE FOR FULL AGENDA

DexCom, Inc.

Annual Meeting of Stockholders

THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR PROPOSAL(S) 1, 2, 3, AND 4.

PROPOSAL

To elect four Class II directors to hold office until our 2023 Annual Meeting of Stockholders presented by our Board of Directors:

1.01

Steven R. Altman

1.02

Barbara E. Kahn

1.03

Kyle Malady

1.04

Jay S. Skyler, M.D., MACP

To ratify the selection by the Audit Committee of our Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022.

To hold a non-binding vote on an advisory resolution to approve executive compensation.

To approve the amendment and restatement of our Restated Certificate of Incorporation to (i) effect a 4:1 forward split of our Common Stock (the "Forward Stock Split") and (ii) increase the number of shares of authorized Common Stock to effectuate the Forward Stock Split.

Such other business properly brought before the meeting or any adjournment or postponement thereof.